Skip to content
The Nexus
DossierENTITY

Shoreline Therapeutics

Coverage of Shoreline Therapeutics in the Nexus archive.

Earliest in view: Jul 2 · 17:32 UTCMost recent: Jul 2 · 17:32 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJul 2 · 17:32 UTCSTAT NEWS
    STAT+: Up and down the ladder: The latest comings and goings

    Protillion Biosciences hired Robert Hollingsworth as chief scientific officer. He previously held the same role at Shoreline Therapeutics and worked at Pfizer as vice president and chief scientific officer of cancer vaccines and immunotherapeutics.

Shoreline Therapeutics · Dossier · The Nexus